3.49

2.35% 0.08

After Hours: 3.49

Sana Biotechnology Inc (SANA)

Overview News Price History Option Chain Financials Why SANA Down? Discussions Forecast

Sana Biotechnology Inc stock is traded at $3.49, with a volume of 1.62M. It is up +2.35% in the last 24 hours and up +9.06% over the past month. Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Previous Close:

$3.41

Open:

$3.47

24h Volume:

1.62M

Relative Volume:

0.57

Market Cap:

$942.27M

Revenue:

Net Income/Loss:

$-244.17M

P/E Ratio:

-3.5747

EPS:

-0.9763

Net Cash Flow:

$-144.77M

1W Performance:

+4.18%

1M Performance:

+9.06%

6M Performance:

-14.46%

1Y Performance:

+86.63%

1-Day Range:

$3.37

$3.56

1-Week Range:

$3.045

$3.56

52-Week Range:

$1.60

$6.55

Sana Biotechnology Inc Stock (SANA) Company Profile

Name

Sana Biotechnology Inc

Sector

Healthcare (1106)

Industry

Biotechnology (615)

Phone

(206) 701-7914

Address

188 EAST BLAINE STREET, SUITE 350, SEATTLE

Employee

142

Twitter

Next Earnings Date

2026-05-14

Latest SEC Filings

SANA's Discussions on Twitter

Compare SANA vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SANA Sana Biotechnology Inc	3.49	920.67M	0	-244.17M	-144.77M	-0.9763
VRTX Vertex Pharmaceuticals Inc	424.36	109.34B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	74.35B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	50.44B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	39.78B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.02B	5.36B	287.73M	924.18M	2.5229

Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-24-25	Initiated	Wedbush	Outperform
Jul-03-25	Resumed	Morgan Stanley	Overweight
Mar-18-25	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform
Mar-14-25	Initiated	Jefferies	Buy
Jan-08-25	Upgrade	TD Cowen	Hold → Buy
Nov-05-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-26-24	Initiated	Rodman & Renshaw	Buy
Jan-16-24	Upgrade	H.C. Wainwright	Neutral → Buy
Sep-25-23	Initiated	JMP Securities	Mkt Outperform
Sep-05-23	Initiated	Citigroup	Buy
Aug-14-23	Initiated	TD Cowen	Market Perform
May-02-23	Initiated	H.C. Wainwright	Neutral
Mar-01-21	Initiated	BofA Securities	Buy
Mar-01-21	Initiated	Goldman	Neutral
Mar-01-21	Initiated	JP Morgan	Neutral
Mar-01-21	Initiated	Morgan Stanley	Overweight

View All

Sana Biotechnology Inc Stock (SANA) Latest News

May 05, 2026

Sana CEO Steve Harr to give business update in May 12 webcast - Stock Titan

May 05, 2026

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference - The Globe and Mail

May 05, 2026

May 04, 2026

MSN Money - MSN

May 04, 2026

May 01, 2026

SANA stock rallies 24% after hours — how much is Mayo Clinic investing in the company? - MSN

May 01, 2026

Apr 29, 2026

Sana Biotechnology (NASDAQ:SANA) Shares Down 7.3%Time to Sell? - MarketBeat

Apr 29, 2026

Apr 27, 2026

Sana Biotechnology abstract accepted for presentation at ASGCT By Investing.com - Investing.com India

Apr 27, 2026

Sana Biotechnology to present preclinical CAR-T data at May meeting - Investing.com

Apr 27, 2026

Sana Biotechnology abstract accepted for presentation at ASGCT - Investing.com

Apr 27, 2026

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting - ChartMill

Apr 27, 2026

Sana Biotech surges as Eric Jackson calls it a 100-bagger - MSN

Apr 27, 2026

Sana Biotech (SANA), Mayo Clinic Partner to Advance Cell Therapy for Type 1 Diabetes - Yahoo Finance

Apr 27, 2026

Apr 26, 2026

Sana Biotech rises as Mayo Clinic partners for diabetes therapy - MSN

Apr 26, 2026

Sana Biotech Stock Jumps A Whopping 35% After Eric Jackson Calls It ‘Next 100-Bagger Platform’ - MSN

Apr 26, 2026

Apr 25, 2026

Wall Street Zen Downgrades Sana Biotechnology (NASDAQ:SANA) to Strong Sell - MarketBeat

Apr 25, 2026

Apr 24, 2026